Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Key Information
Due Date: January 17, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant is designed to offer preclinical services that function to bridge gaps in product development. The purpose of this Funding Opportunity Announcement (FOA) is to support and streamline the process of developing potential treatments specifically targeted towards HIV and related co-infections such as Hepatitis B, Hepatitis C, and Tuberculosis.
This grant primarily serves to benefit academic and private institutions actively involved in the discovery and development of such therapies. The objective is to offer assistance to these entities to advance their research and realize the potential of promising HIV-related therapeutics swiftly and successfully.
Key Dates
Open Date: May 27, 2022
Application Due Date: January 17, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses